International Medical Device Regulators Forum (IMDRF)
We strategically accelerate international medical device regulatory convergence to promote an efficient and effective regulatory model for medical devices that is responsive to emerging challenges while protecting and maximizing public health and safety.
Learn more about us through this short video
At the September Meeting, the IMDRF Management Committee welcomed The Saudi Food and Drug Authority (SFDA), Saudi Arabia as an IMDRF Official Observer.
The Management Committee also welcomed the following new Affiliate Members:
BOMRA, Botswana
Ministry of Health, Costa Rica
DIGEMAPS, Dominican Republic
CDSCO, India
Medical Device Control Department, Oman
DINAVISA, Paraguay
DIGEMID, Peru
MCAZ, Zimbabwe
Contacts will be available on the Official Observer and Affiliate Membership pages as they become available.
Presentations and the Outcome Statement from the 26th IMDRF Management Committee Session held in September 2024 in Seattle, Washington are available here.
The 27th IMDRF Management Committee sessions will be held 10-14 March 2025 in Tokyo, Japan. Details on how to register for the event can be found here.
The 2024 IMDRF Chair and Secretariat is held by the United States of America. Upcoming rotations of the Chair and Secretariat can be viewed here.
The impact of COVID-19
The International Medical Device Regulators Forum (IMDRF) acknowledges the significant impact of the COVID-19 pandemic on all countries and citizens. The use of essential medical devices such as ventilators, oxygen concentrators, syringes and test kits contributed to the efforts of pandemic responses around the world, as with other products regulated in some countries such as surgical face masks.
The IMDRF held a Joint Workshop on COVID-19 in March 2021 and held regular discussions about the impacts, experiences and challenges during the pandemic. Members continue to share information about changes made to regulatory frameworks that aim to assist preparations for future pandemics. Some of these included emergency use or other systems to expedite access and supply of essential medical devices, flexible and pragmatic approaches to regulatory processes such as remote inspections, and publishing information about approval pathways and availability of critical medical devices.
A link to each member country's website is below, where you can find more detailed information.